169 related articles for article (PubMed ID: 36647117)
1. CIC reduces xCT/SLC7A11 expression and glutamate release in glioma.
Park JW; Kilic O; Deo M; Jimenez-Cowell K; Demirdizen E; Kim H; Turcan Ş
Acta Neuropathol Commun; 2023 Jan; 11(1):13. PubMed ID: 36647117
[TBL] [Abstract][Full Text] [Related]
2. Capicua (CIC) mutations in gliomas in association with MAPK activation for exposing a potential therapeutic target.
Darabi S; Xiu J; Samec T; Kesari S; Carrillo J; Aulakh S; Walsh KM; Sengupta S; Sumrall A; Spetzler D; Glantz M; Demeure MJ
Med Oncol; 2023 Jun; 40(7):197. PubMed ID: 37291277
[TBL] [Abstract][Full Text] [Related]
3. High expression of cystine-glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma.
Sørensen MF; Heimisdóttir SB; Sørensen MD; Mellegaard CS; Wohlleben H; Kristensen BW; Beier CP
J Neurooncol; 2018 May; 138(1):49-53. PubMed ID: 29404978
[TBL] [Abstract][Full Text] [Related]
4. SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma.
Robert SM; Buckingham SC; Campbell SL; Robel S; Holt KT; Ogunrinu-Babarinde T; Warren PP; White DM; Reid MA; Eschbacher JM; Berens ME; Lahti AC; Nabors LB; Sontheimer H
Sci Transl Med; 2015 May; 7(289):289ra86. PubMed ID: 26019222
[TBL] [Abstract][Full Text] [Related]
5. Integrative multi-omic analysis reveals neurodevelopmental gene dysregulation in CIC-knockout and IDH1-mutant cells.
Lee SD; Song J; LeBlanc VG; Marra MA
J Pathol; 2022 Mar; 256(3):297-309. PubMed ID: 34767259
[TBL] [Abstract][Full Text] [Related]
6. CIC inactivating mutations identify aggressive subset of 1p19q codeleted gliomas.
Gleize V; Alentorn A; Connen de Kérillis L; Labussière M; Nadaradjane AA; Mundwiller E; Ottolenghi C; Mangesius S; Rahimian A; Ducray F; ; Mokhtari K; Villa C; Sanson M
Ann Neurol; 2015 Sep; 78(3):355-74. PubMed ID: 26017892
[TBL] [Abstract][Full Text] [Related]
7. Comparative transcriptome analysis of isogenic cell line models and primary cancers links capicua (CIC) loss to activation of the MAPK signalling cascade.
LeBlanc VG; Firme M; Song J; Chan SY; Lee MH; Yip S; Chittaranjan S; Marra MA
J Pathol; 2017 Jun; 242(2):206-220. PubMed ID: 28295365
[TBL] [Abstract][Full Text] [Related]
8. Capicua regulates neural stem cell proliferation and lineage specification through control of Ets factors.
Ahmad ST; Rogers AD; Chen MJ; Dixit R; Adnani L; Frankiw LS; Lawn SO; Blough MD; Alshehri M; Wu W; Marra MA; Robbins SM; Cairncross JG; Schuurmans C; Chan JA
Nat Commun; 2019 May; 10(1):2000. PubMed ID: 31043608
[TBL] [Abstract][Full Text] [Related]
9.
Yang R; Chen LH; Hansen LJ; Carpenter AB; Moure CJ; Liu H; Pirozzi CJ; Diplas BH; Waitkus MS; Greer PK; Zhu H; McLendon RE; Bigner DD; He Y; Yan H
Cancer Res; 2017 Nov; 77(22):6097-6108. PubMed ID: 28939681
[TBL] [Abstract][Full Text] [Related]
10. A double-edged sword: The world according to Capicua in cancer.
Tanaka M; Yoshimoto T; Nakamura T
Cancer Sci; 2017 Dec; 108(12):2319-2325. PubMed ID: 28985030
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of Capicua in adult mice causes T-cell lymphoblastic lymphoma.
Simón-Carrasco L; Graña O; Salmón M; Jacob HKC; Gutierrez A; Jiménez G; Drosten M; Barbacid M
Genes Dev; 2017 Jul; 31(14):1456-1468. PubMed ID: 28827401
[TBL] [Abstract][Full Text] [Related]
12. Capicua Regulates Dendritic Morphogenesis Through Ets in Hippocampal Neurons
Li K; Shao S; Ji T; Liu M; Wang L; Pang Y; Chen M; Xu S; Zhang K; Wang Q; Zhuang Z; Wei L; Zhang Y; Chen Y; Wang Y; Zhang J; Chen K; Lian H; Zhong C
Front Neuroanat; 2021; 15():669310. PubMed ID: 34385910
[TBL] [Abstract][Full Text] [Related]
13. Capicua suppresses colorectal cancer progression via repression of ETV4 expression.
Lee JS; Kim E; Lee J; Kim D; Kim H; Kim CJ; Kim S; Jeong D; Lee Y
Cancer Cell Int; 2020; 20():42. PubMed ID: 32042269
[TBL] [Abstract][Full Text] [Related]
14. c-Src Phosphorylates and Inhibits the Function of the CIC Tumor Suppressor Protein.
Bunda S; Heir P; Li ASC; Mamatjan Y; Zadeh G; Aldape K
Mol Cancer Res; 2020 May; 18(5):774-786. PubMed ID: 32029440
[TBL] [Abstract][Full Text] [Related]
15. Making heads or tails - the emergence of capicua (CIC) as an important multifunctional tumour suppressor.
Wong D; Yip S
J Pathol; 2020 Apr; 250(5):532-540. PubMed ID: 32073140
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor promotes glioma progression by regulating xCT and GluN2B-containing N-methyl-d-aspartate-sensitive glutamate receptor signaling.
Suina K; Tsuchihashi K; Yamasaki J; Kamenori S; Shintani S; Hirata Y; Okazaki S; Sampetrean O; Baba E; Akashi K; Mitsuishi Y; Takahashi F; Takahashi K; Saya H; Nagano O
Cancer Sci; 2018 Dec; 109(12):3874-3882. PubMed ID: 30298963
[TBL] [Abstract][Full Text] [Related]
17. Mutations in CIC and IDH1 cooperatively regulate 2-hydroxyglutarate levels and cell clonogenicity.
Chittaranjan S; Chan S; Yang C; Yang KC; Chen V; Moradian A; Firme M; Song J; Go NE; Blough MD; Chan JA; Cairncross JG; Gorski SM; Morin GB; Yip S; Marra MA
Oncotarget; 2014 Sep; 5(17):7960-79. PubMed ID: 25277207
[TBL] [Abstract][Full Text] [Related]
18. The crystal structure of Capicua HMG-box domain complexed with the ETV5-DNA and its implications for Capicua-mediated cancers.
Lee H; Song JJ
FEBS J; 2019 Dec; 286(24):4951-4963. PubMed ID: 31323153
[TBL] [Abstract][Full Text] [Related]
19. CIC is a critical regulator of neuronal differentiation.
Hwang I; Pan H; Yao J; Elemento O; Zheng H; Paik J
JCI Insight; 2020 May; 5(9):. PubMed ID: 32229723
[TBL] [Abstract][Full Text] [Related]
20. Novel CIC point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing.
Eisenreich S; Abou-El-Ardat K; Szafranski K; Campos Valenzuela JA; Rump A; Nigro JM; Bjerkvig R; Gerlach EM; Hackmann K; Schröck E; Krex D; Kaderali L; Schackert G; Platzer M; Klink B
PLoS One; 2013; 8(9):e76623. PubMed ID: 24086756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
